The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas

Journal of Cutaneous Pathology

Volumn 31, Issue 2, 2004, Pages 145-152

  Qureshi, Hina S ^a   Ormsby, Adrian H ^a   Lee, Min W ^a   Zarbo, Richard J ^a   Ma, Chan K ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN CK5; PROTEIN CK6; PROTEIN CK7; PROTEIN P63; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; SEBACEOUS CARCINOMA; SKIN CARCINOMA; SWEAT GLAND CARCINOMA; TUMOR CELL; UROGENITAL TRACT TUMOR;

CARCINOMA; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KERATINS; MEMBRANE PROTEINS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 1642439910     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00147.x     Document Type: Article

References (19)

1. Wick MR, Swanson PE, Ritter JH, Fitzgibbon JF. The immunohistology of cutaneous neoplasia: a practical perspective. J Cutan Pathol 1993; 20: 481.
2. Kanitakis J. Solid cutaneous tumors. In: Kanitakis J, Vassileva S, Woodley D, eds. Diagnostic immunohistochemistry of the skin - an illustrated text, London: Chapman & Hall, 1998, 279.
3. Plumb SJ, Stone MS, De Young BR. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms. Mod Pathol 2002; 15: 105A.
4. Plumb S, De Young B, Stone M. Cytokeratin 5/6 immunostaining in metastatic adenocarcinoma. J Cutan Pathol 2003; 30: 78.
5. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms. An immunohistochemical study of 509 cases. Mod Pathol 2002; 15: 6.
6. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/ 6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116: 823.
7. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma. Histopathology 1997; 31: 140.
8. Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelioid mesothilioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998; 22: 1215.
9. Yang A, Kaghad M, Wang Y, et al. p63, ap53 homolog at 3q27, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305.
10. Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000; 157: 1769.
11. Reis-Filho JS, Torio B, Albergaria A, Schmitt FG. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002; 29: 517.
12. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999; 113: 1099.
13. Yamaguchi K, Wu L, Caballero OL, et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck suqamous cell carcinoma. Int J Cancer 2000; 86: 684.
14. Chu P, Wu M, Weiss LM. Cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 2000; 13: 962.
15. Ramaekers F, van Niekerk C, Poels L, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990; 136: 641.
16. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427.
17. Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 2000; 13: 107.
18. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002; 8: 494.
19. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonie carcinoma. Mod Pathol 1996; 9: 426.